With the acquisition of Hospira Infusion Systems in 2017 and Smiths Medical in 2022, we are now a global market leader with a complete line of clinically-essential IV therapy and high-value critical care products for hospital, alternate site, and home care settings. Master presentation skills and share technical knowledge of the ICU family of products and how they relate to guidelines FDA, CDC, SHEA, INS, ONS, ASHP, etc. in order to communicate professionally with Hospital Clinicians.